Use of Actigraphy (Wearable Digital Sensors to Monitor Activity) in Heart Failure Randomized Clinical Trials: A Scoping Review

Canadian Journal of Cardiology - Tập 37 - Trang 1438-1449 - 2021
Khalil Anchouche1,2, Malik Elharram1,2, Emily Oulousian1,2, Amir Razaghizad1,2, Robert Avram3,4,5, Guillaume Marquis-Gravel5, Varinder Kaur Randhawa6, Richard Nkulikiyinka7, Wei Ni8, Mona Fiuzat9, Christopher O'Connor9,10, Mitchell A. Psotka10, Jonathan Fox11, Benoit Tyl12, David Kao13, Abhinav Sharma1,2
1Division of Cardiology, McGill University Health Centre, McGill University, Montréal, Québec, Canada
2DREAM-CV Lab, McGill University Health Centre, McGill University, Montréal, Québec, Canada
3Division of Cardiology, Department of Medicine, Ottawa Heart Institute, University of Ottawa, Ottawa, Ontario, Canada
4Division of Cardiology, University of California-San Francisco, San Francisco, California, USA
5Montréal Heart Institute, Université de Montréal, Montréal, Québec, Canada
6Department of Cardiovascular Medicine, Kaufman Center for Heart Failure, Heart, Vascular and Thoracic Institute, Cleveland, Ohio, USA
7Research and Development, Pharmaceuticals, Bayer, Wuppertal, Germany
8Eli Lilly and Company, Indianapolis, Indiana, USA.
9Division of Cardiology, Duke University, Durham, North Carolina, USA
10Inova Heart and Vascular Institute, Falls Church, Virginia, USA
11Eidos Therapeutics, San Francisco, California, USA
12Center for Therapeutic Innovation Cardiovascular and Metabolic diseases, Institut de Recherches Internationales Servier, Suresnes, France
13Department of Medicine, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA

Tài liệu tham khảo

Savarese, 2017, Global public health burden of heart failure, Card Fail Rev, 3, 7, 10.15420/cfr.2016:25:2 Tran, 2016, The current and future financial burden of hospital admissions for heart failure in Canada: a cost analysis, CMAJ Open, 4, e365, 10.9778/cmajo.20150130 Curtis, 2008, Early and long-term outcomes of heart failure in elderly persons, 2001–2005, Arch Intern Med, 168, 2481, 10.1001/archinte.168.22.2481 Rossignol, 2019, Heart failure drug treatment, Lancet, 393, 1034, 10.1016/S0140-6736(18)31808-7 Allen, 2009, End points for clinical trials in acute heart failure syndromes, J Am Coll Cardiol, 53, 2248, 10.1016/j.jacc.2008.12.079 Tricco, 2018, PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation, Ann Intern Med, 169, 467, 10.7326/M18-0850 Sterne, 2019, RoB 2: a revised tool for assessing risk of bias in randomised trials, BMJ, 366, l4898, 10.1136/bmj.l4898 Khandwalla, 2021, The AWAKE-HF study: sacubitril/valsartan impact on daily physical activity and sleep in heart failure, Am J Cardiovasc Drugs, 21, 241, 10.1007/s40256-020-00440-y Hetzenecker, 2016, Treatment of sleep apnea in chronic heart failure patients with auto-servo ventilation improves sleep fragmentation: a randomized controlled trial, Sleep Med, 17, 25, 10.1016/j.sleep.2015.08.020 Redeker, 2015, Feasibility and efficacy of a self-management intervention for insomnia in stable heart failure, J Clin Sleep Med, 11, 1109, 10.5664/jcsm.5082 van den Berg-Emons, 2004, Does aerobic training lead to a more active lifestyle and improved quality of life in patients with chronic heart failure?, Eur J Heart Fail, 6, 95, 10.1016/j.ejheart.2003.10.005 Borlaug, 2018, Effect of inorganic nitrite vs placebo on exercise capacity among patients with heart failure with preserved ejection fraction: the INDIE-HFpEF randomized clinical trial, JAMA, 320, 1764, 10.1001/jama.2018.14852 Cowie, 2011, A comparison of home and hospital-based exercise training in heart failure: immediate and long-term effects upon physical activity level, Eur J Cardiovasc Prev Rehabil, 18, 158, 10.1177/1741826710389389 Deka, 2019, MOVE-HF: an internet-based pilot study to improve adherence to exercise in patients with heart failure, Eur J Cardiovasc Nurs, 18, 122, 10.1177/1474515118796613 Redfield, 2015, Isosorbide mononitrate in heart failure with preserved ejection fraction, N Engl J Med, 373, 2314, 10.1056/NEJMoa1510774 Witham, 2010, The effects of vitamin D supplementation on physical function and quality of life in older patients with heart failure: a randomized controlled trial, Circ Heart Fail, 3, 195, 10.1161/CIRCHEARTFAILURE.109.907899 Witham, 2005, Effect of a seated exercise program to improve physical function and health status in frail patients >or = 70 years of age with heart failure, Am J Cardiol, 95, 1120, 10.1016/j.amjcard.2005.01.031 Piepoli, 2021, OUTSTEP-HF: randomised controlled trial comparing short-term effects of sacubitril/valsartan versus enalapril on daily physical activity in patients with chronic heart failure with reduced ejection fraction, Eur J Heart Fail, 23, 127, 10.1002/ejhf.2076 Study to assess the effect of omecamtiv mecarbil on exercise capacity in subjects with heart failure (METEORIC-HF). Available at: https://clinicaltrials.gov/ct2/show/NCT03759392. Accessed May 1, 2021. A study on impact of canagliflozin on health status, quality of life, and functional status in heart failure (CHIEF-HF). Available at: https://clinicaltrials.gov/ct2/show/NCT04252287. Accessed May 1, 2021. DETERMINE-preserved—dapagliflozin effect on exercise capacity using a 6-minute walk test in patients with heart failure with preserved ejection fraction. Available at: https://clinicaltrials.gov/ct2/show/NCT03877224. Accessed May 1, 2021. DETERMINE-reduced—dapagliflozin effect on exercise capacity using a 6-minute walk test in patients with heart failure with reduced ejection fraction. Available at: https://clinicaltrials.gov/ct2/show/NCT03877237. Accessed May 1, 2021. Randomized study using accelerometry to compare sacubitril/valsartan and enalapril in patients with heart failure (OUTSTEP-HF). Available at: https://clinicaltrials.gov/ct2/show/NCT02900378. Accessed May 1, 2021. Patient-reported outcomes in vericiguat-treated patients with HFpEF (VITALITY-HFpEF). Available at: https://clinicaltrials.gov/ct2/show/NCT03547583. Accessed May 1, 2021. Joyce, 2016, Variable contribution of heart failure to quality of life in ambulatory heart failure with reduced, better, or preserved ejection fraction, JACC Heart Fail, 4, 184, 10.1016/j.jchf.2015.12.011 Wang, 2005, Does this dyspneic patient in the emergency department have congestive heart failure?, JAMA, 294, 1944, 10.1001/jama.294.15.1944 Cowie, 2017, Sleep disordered breathing and heart failure: what does the future hold?, JACC Heart Fail, 5, 715, 10.1016/j.jchf.2017.06.016 Manemann, 2018, Perceived social isolation and outcomes in patients with heart failure, J Am Heart Assoc, 7, 10.1161/JAHA.117.008069 Tan, 2019, Can activity monitors predict outcomes in patients with heart failure? A systematic review, Eur Heart J Qual Care Clin Outcomes, 5, 11, 10.1093/ehjqcco/qcy038 Burns, 2020, International Consortium for Health Outcomes Measurement (ICHOM): standardized patient-centered outcomes measurement set for heart failure patients, JACC Heart Fail, 8, 212, 10.1016/j.jchf.2019.09.007 McMurray, 2014, Angiotensin–neprilysin inhibition versus enalapril in heart failure, N Engl J Med, 371, 993, 10.1056/NEJMoa1409077 Beltrán, 2018, Sacubitril/valsartan and short-term changes in the 6-minute walk test: a pilot study, Int J Cardiol, 252, 136, 10.1016/j.ijcard.2017.10.074 Khariton, 2019, Association between sacubitril/valsartan initiation and health status outcomes in heart failure with reduced ejection fraction, JACC Heart Fail, 7, 933, 10.1016/j.jchf.2019.05.016 Marino, 2013, Measuring sleep: accuracy, sensitivity, and specificity of wrist actigraphy compared to polysomnography, Sleep, 36, 1747, 10.5665/sleep.3142 Dontje, 2014, Daily physical activity in stable heart failure patients, J Cardiovasc Nurs, 29, 218, 10.1097/JCN.0b013e318283ba14 Maurer, 2009, The prevalence and impact of anergia (lack of energy) in subjects with heart failure and its associations with actigraphy, J Card Fail, 15, 145, 10.1016/j.cardfail.2008.10.021 Lavie, 2019, Sedentary behavior, exercise, and cardiovascular health, Circ Res, 124, 799, 10.1161/CIRCRESAHA.118.312669 Sarkar, 2009, Self-efficacy as a marker of cardiac function and predictor of heart failure hospitalization and mortality in patients with stable coronary heart disease: findings from the Heart and Soul Study, Health Psychol, 28, 166, 10.1037/a0013146 Celano, 2018, Depression and anxiety in heart failure: a review, Harv Rev Psychiatry, 26, 175, 10.1097/HRP.0000000000000162 Wood, 2004, Are missing outcome data adequately handled? A review of published randomized controlled trials in major medical journals, Clin Trials, 1, 368, 10.1191/1740774504cn032oa Bennett, 2001, How can I deal with missing data in my study?, Aust N Z J Public Health, 25, 464, 10.1111/j.1467-842X.2001.tb00294.x Mathieu, 2009, Comparison of registered and published primary outcomes in randomized controlled trials, JAMA, 302, 977, 10.1001/jama.2009.1242 Feehan, 2018, Accuracy of Fitbit devices: systematic review and narrative syntheses of quantitative data, JMIR Mhealth Uhealth, 6, e10527, 10.2196/10527 Fraiche, 2017, Moving beyond the walls of the clinic: opportunities and challenges to the future of telehealth in heart failure, JACC Heart Fail, 5, 297, 10.1016/j.jchf.2016.11.013 Sharma, 2018, Using digital health technology to better generate evidence and deliver evidence-based care, J Am Coll Cardiol, 71, 2680, 10.1016/j.jacc.2018.03.523 Patel, 2018, Narrowing the disparities in heart failure: treat the event or try to prevent?, JACC Heart Fail, 6, 410, 10.1016/j.jchf.2018.01.019 47Marquis-Gravel, 2019, Technology-enabled clinical trials: transforming medical evidence generation, Circulation, 140, 1426, 10.1161/CIRCULATIONAHA.119.040798 DeVore, 2019, The future of wearables in heart failure patients, JACC Heart Fail, 7, 922, 10.1016/j.jchf.2019.08.008 Benjamin, 2018, Heart disease and stroke statistics—2018 update: a report from the American Heart Association, Circulation, 137, e67, 10.1161/CIR.0000000000000558